118 related articles for article (PubMed ID: 18792899)
1. Concomitant presence of mutations in mitochondrial genome and p53 in cancer development - a study in north Indian sporadic breast and esophageal cancer patients.
Gochhait S; Bhatt A; Sharma S; Singh YP; Gupta P; Bamezai RN
Int J Cancer; 2008 Dec; 123(11):2580-6. PubMed ID: 18792899
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer.
Darvishi K; Sharma S; Bhat AK; Rai E; Bamezai RN
Cancer Lett; 2007 May; 249(2):249-55. PubMed ID: 17081685
[TBL] [Abstract][Full Text] [Related]
3. Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations.
Barekati Z; Radpour R; Kohler C; Zhang B; Toniolo P; Lenner P; Lv Q; Zheng H; Zhong XY
Hum Mol Genet; 2010 Aug; 19(15):2936-46. PubMed ID: 20466735
[TBL] [Abstract][Full Text] [Related]
4. Correlation of telomere length shortening with TP53 somatic mutations, polymorphisms and allelic loss in breast tumors and esophageal cancer.
Hao XD; Yang Y; Song X; Zhao XK; Wang LD; He JD; Kong QP; Tang NL; Zhang YP
Oncol Rep; 2013 Jan; 29(1):226-36. PubMed ID: 23124483
[TBL] [Abstract][Full Text] [Related]
5. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation.
Kuo SJ; Chen M; Ma GC; Chen ST; Chang SP; Lin WY; Chen YC; Lee TH; Lin TT; Liu CS
Cancer Genet Cytogenet; 2010 Sep; 201(2):94-101. PubMed ID: 20682393
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations of the mitochondrial genome in human breast cancers.
Tseng LM; Yin PH; Yang CW; Tsai YF; Hsu CY; Chi CW; Lee HC
Genes Chromosomes Cancer; 2011 Oct; 50(10):800-11. PubMed ID: 21748819
[TBL] [Abstract][Full Text] [Related]
7. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.
Lin CS; Chang SC; Ou LH; Chen CM; Hsieh SS; Chung YP; King KL; Lin SL; Wei YH
Oncol Rep; 2015 Jun; 33(6):2924-34. PubMed ID: 25845386
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
[TBL] [Abstract][Full Text] [Related]
10. Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma.
Kumimoto H; Yamane Y; Nishimoto Y; Fukami H; Shinoda M; Hatooka S; Ishizaki K
Int J Cancer; 2004 Jan; 108(2):228-31. PubMed ID: 14639607
[TBL] [Abstract][Full Text] [Related]
11. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
[TBL] [Abstract][Full Text] [Related]
12. Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma.
Abnet CC; Huppi K; Carrera A; Armistead D; McKenney K; Hu N; Tang ZZ; Taylor PR; Dawsey SM
BMC Cancer; 2004 Jul; 4():30. PubMed ID: 15230979
[TBL] [Abstract][Full Text] [Related]
13. p53 in breast cancer subtypes and new insights into response to chemotherapy.
Bertheau P; Lehmann-Che J; Varna M; Dumay A; Poirot B; Porcher R; Turpin E; Plassa LF; de Roquancourt A; Bourstyn E; de Cremoux P; Janin A; Giacchetti S; Espié M; de Thé H
Breast; 2013 Aug; 22 Suppl 2():S27-9. PubMed ID: 24074787
[TBL] [Abstract][Full Text] [Related]
14. Part II. Mitochondrial mutational status of high nitric oxide adapted cell line BT-20 (BT-20-HNO) as it relates to human primary breast tumors.
De Vitto H; Mendonça BS; Elseth KM; Vesper BJ; Portari EA; Gallo CV; Paradise WA; Rumjanek FD; Radosevich JA
Tumour Biol; 2013 Feb; 34(1):337-47. PubMed ID: 23238816
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer.
Tseng LM; Yin PH; Chi CW; Hsu CY; Wu CW; Lee LM; Wei YH; Lee HC
Genes Chromosomes Cancer; 2006 Jul; 45(7):629-38. PubMed ID: 16568452
[TBL] [Abstract][Full Text] [Related]
16. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
17. Associated microsatellite alterations in mitochondrial DNA and in TP53 in thoracic esophageal squamous cell carcinoma.
Lin CS; Wang LS; Chang SC; Chou TY; Hsu WH; Liu CS; Lee MH; Chung MY; Wei YH
Oncol Rep; 2012 Jul; 28(1):69-76. PubMed ID: 22505350
[TBL] [Abstract][Full Text] [Related]
18. Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients.
Yu M; Zhou Y; Shi Y; Ning L; Yang Y; Wei X; Zhang N; Hao X; Niu R
IUBMB Life; 2007 Jul; 59(7):450-7. PubMed ID: 17654121
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
[TBL] [Abstract][Full Text] [Related]
20. Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection.
Fendt L; Niederstätter H; Huber G; Zelger B; Dünser M; Seifarth C; Röck A; Schäfer G; Klocker H; Parson W
Breast Cancer Res Treat; 2011 Jul; 128(2):327-36. PubMed ID: 20697806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]